Cargando…

Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures

SIMPLE SUMMARY: Extramedullary multiple myeloma (EMM) is a rare and aggressive subtype of multiple myeloma which is associated with a poor prognosis. Here, we used mass spectrometry to illustrate that extramedullary multiple myeloma patients have a bone marrow and plasma protein signature that is di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunphy, Katie, Bazou, Despina, Henry, Michael, Meleady, Paula, Miettinen, Juho J., Heckman, Caroline A., Dowling, Paul, O’Gorman, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417544/ https://www.ncbi.nlm.nih.gov/pubmed/37568580 http://dx.doi.org/10.3390/cancers15153764

Ejemplares similares

Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
por: Dowling, Paul, et al.
Publicado: (2021)

Clinical Proteomics of Biofluids in Haematological Malignancies
por: Dunphy, Katie, et al.
Publicado: (2021)

Using Proteomics Data to Identify Personalized Treatments in Multiple Myeloma: A Machine Learning Approach
por: Katsenou, Angeliki, et al.
Publicado: (2023)

Current Methods of Post-Translational Modification Analysis and Their Applications in Blood Cancers
por: Dunphy, Katie, et al.
Publicado: (2021)

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients
por: Tierney, Ciara, et al.
Publicado: (2021)

Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients
por: Ting, Kay Reen, et al.
Publicado: (2017)

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
por: Blum, Agnieszka, et al.
Publicado: (2018)

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma
por: Liu, Minxia, et al.
Publicado: (2021)

Marizomib: A novel therapeutic approach for the treatment of central nervous system myeloma
por: Bazou, Despina, et al.
Publicado: (2020)

Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen
por: Miettinen, Juho J., et al.
Publicado: (2021)

Extramedullary relapse of IgA-lambda myeloma after recent bortezomib therapy: a case report
por: Waterhouse, Deirdre F, et al.
Publicado: (2009)

Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types
por: Majumder, Muntasir M., et al.
Publicado: (2020)

Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen
por: Gebraad, Arjen, et al.
Publicado: (2022)

P939: THE RELATIONSHIP OF BONE MARROW FIBROSIS WITH EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
por: Konyaoglu, Hilal, et al.
Publicado: (2023)

Bone Disease in Multiple Myeloma: Pathophysiology and Management
por: Hameed, Abdul, et al.
Publicado: (2014)

Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma
por: Xia, Yuan, et al.
Publicado: (2022)

Extramedullary Multiple Myeloma: A Patient-Focused Review of the Pathogenesis of Bone Marrow Escape
por: Gupta, Supriya, et al.
Publicado: (2022)

An imaging review of extramedullary myeloma
por: Kay, M, et al.
Publicado: (2015)

Extramedullary disease in multiple myeloma
por: Bansal, Radhika, et al.
Publicado: (2021)

Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease
por: Hirao, Maki, et al.
Publicado: (2022)

Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
por: Batsukh, Khishigjargal, et al.
Publicado: (2017)

Bleeding and Thrombosis in Multiple Myeloma: Platelets as Key Players during Cell Interactions and Potential Use as Drug Delivery Systems
por: Kulkarni, Anushka, et al.
Publicado: (2023)

Multiple myeloma with huge extramedullary plasmacytomas
por: Bae, Soo-Young, et al.
Publicado: (2010)

Extramedullary Multiple Myeloma with Hepatic Involvement
por: Singh, Manpreet, et al.
Publicado: (2021)

Daratumumab efficacy in extramedullary orbital myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2020)

Genetic Abnormalities in Extramedullary Multiple Myeloma
por: McAvera, Roisin, et al.
Publicado: (2023)

Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities
por: Kriegova, Eva, et al.
Publicado: (2021)

Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement
por: Español, Ignacio, et al.
Publicado: (2017)

Advances in the treatment of extramedullary disease in multiple myeloma
por: Li, Yating, et al.
Publicado: (2022)

Multifocal Extramedullary Plasma Cell Myeloma of the Colon
por: Karime, Christian, et al.
Publicado: (2023)

Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease
por: Dowling, Paul, et al.
Publicado: (2014)

Secondary Extramedullary Myeloma of the Gallbladder: A Case Report
por: Kolagatla, Sandhya, et al.
Publicado: (2022)

Distinct promoter methylation profile reveals spatial epigenetic heterogeneity in 2 myeloma patients with multifocal extramedullary relapses
por: Yao, Qiumei, et al.
Publicado: (2018)

P426: HDAC INHIBITORS RESTORE SENSITIVITY TO VENETOCLAX AND NAVITOCLAX IN AML CELLS RESULTING IN THE IRREVERSIBLE DNA DAMAGE
por: Khabusheva, Elmira, et al.
Publicado: (2023)

Metabolomics in the identification of biomarkers of dietary intake
por: O'Gorman, Aoife, et al.
Publicado: (2013)

Integrated Transcriptomic Analysis Reveals a Distinctive Role of YAP1 in Extramedullary Invasion and Therapeutic Sensitivity of Multiple Myeloma
por: Zheng, Bo, et al.
Publicado: (2022)

Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis
por: Ho Zhi Guang, Matthew, et al.
Publicado: (2019)

Detection of Extramedullary Multiple Myeloma in Liver by FDG-PET/CT
por: Kim, Dae-Weung, et al.
Publicado: (2013)

Relapse of Multiple Myeloma Presenting as Extramedullary Plasmacytomas in Multiple Organs
por: Köse, Murat, et al.
Publicado: (2015)

Clinical features of multiple myeloma patients with isolated extramedullary relapse
por: Qu, Xiaoyan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_72emi34m631q6i17bpjduc54of